GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Moogene Medi Co Ltd (XKRX:322970) » Definitions » Institutional Ownership

Moogene Medi Co (XKRX:322970) Institutional Ownership : 0.00% (As of Mar. 31, 2025)


View and export this data going back to 2020. Start your Free Trial

What is Moogene Medi Co Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Moogene Medi Co's institutional ownership is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Moogene Medi Co's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Moogene Medi Co's Float Percentage Of Total Shares Outstanding is 0.00%.


Moogene Medi Co Institutional Ownership Historical Data

The historical data trend for Moogene Medi Co's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moogene Medi Co Institutional Ownership Chart

Moogene Medi Co Annual Data
Trend
Institutional Ownership

Moogene Medi Co Semi-Annual Data
Institutional Ownership

Moogene Medi Co Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Moogene Medi Co Business Description

Traded in Other Exchanges
N/A
Address
670, Daewangpangyo-ro, Bundang-gu, U-space 2 A-505, Gyeonggi-do, Seongnam-si, KOR
Moogene Medi Co Ltd is a bio-technology company engaged in gene therapy and nano-materials fabrication using cutting-edge nanotechnologies. The company has developed programs to monitor KRAS-mutant cancer strains, androgenic alopecia, type two diabetes, and liver diseases.

Moogene Medi Co Headlines

No Headlines